Why IMU is a multi multi bagger, page-19551

Has anyone seen the changes to the Imugene website? Was just browsing today and noticed they also have job applications targeting people in the USA.


Interesting roles as some are obviously for our new GMP facility in North Carolina, but the ones in San Francisco are of interest to me.

Also on another note I was thinking about our results recently released for Vaxinia in relation to the MAST (Metastatic and Advanced Solid Tumours) aspect of this trial. If we have 1 CR and 1 PR plus another 16 SD at low to mid level doses could this mean that a portion of these results are in Metastatic cancers which means we are observing the Abscopal Effect in Patients? I can't recall reading anything relating to our results of the Monotherapy Data cut of Vaxinia describing exactly what specific cancers they were other than stating Bile Duct Cancer, Melanoma, Pancreatic and Liver if I recall correctly. To be more precise I am curious as to if these are considered only advanced solid tumours that are localised or if they are called their original designated cancer indication that have also metastasised elsewhere and we are seeing disease control from the scans? If so I think this adds huge weight to these results and would be interested to find out if anyone has some more insight or knowledge on this?

Many thanks.